Pictet Asset Management Sa Obs Eva Sa Transaction History

Pictet Asset Management Sa

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.14 - $0.21 $1,095 - $1,642	-7,823 Reduced 2.11%	363,772 $52,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $1.83 $10,667 - $139,438	76,196 Added 25.79%	371,595 $53,000
Q2 2022 Aug 09, 2022	BUY	$1.34 - $2.08 $53,551 - $83,125	39,964 Added 15.65%	295,399 $476,000
Q1 2022 May 13, 2022	BUY	$1.1 - $2.17 $31,876 - $62,884	28,979 Added 12.8%	255,435 $386,000
Q3 2021 Nov 12, 2021	BUY	$2.47 - $3.34 $559,346 - $756,363	226,456 New	226,456 $704,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Sa with notifications on news.